Mechanisms of Notch1 in Aortic Valve Calcification

Notch1在主动脉瓣钙化中的作用机制

基本信息

  • 批准号:
    7561331
  • 负责人:
  • 金额:
    $ 13.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-15 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Aortic valve calcification/stenosis is the third leading cause of adult heart disease and the most common form of acquired valvular disease in developed countries. The risk factors most closely linked to calcific aortic stenosis are the presence of a bicuspid aortic valve, increased age, male gender, smoking, hypertension, and elevated lipoproteins. Examination of human calcified aortic valve tissue has shown that several pathologic pathways are involved. However, the molecular mechanisms involved in valvular calcification have not been elucidated. Recently, the Srivastava lab reported two human families in which mutations in NOTCH1 were associated with early calcification of the aortic valve and bicuspid aortic valves. Notchl is a part of a highly conserved signaling pathway involved in many cellular events, including cell fate decisions and cell differentiation. This study demonstrated that Hrt2, a transcriptional represser that mediates the Notchl signal, could regulate the activity of Runx2, a central regulator of osteoblast cell fate determination in vitro. Our preliminary data show that Notchl heterozygous mice develop increased aortic valve calcification as compared to wild-type age matched littermates. I hypothesize that Notchl signaling represses pro-osteogenic pathways in aortic valve mesenchyme and that Notchl disruption may sensitize the valve to known risk factors that promote calcification. Specific Aim 1: To determine if disrupting Notchl signaling causes calcification of the aortic valve by activation of osteogenic pathways in mice. Notchl signaling will be conditionally disrupted in aortic valve tissue valves prenatally or postnatally. The aortic valves will be examined for functional stenosis, calcification, and expression of genes involved in bone formation. In addition, Notchl-deficient mice will be crossed with a mouse model of hyperlipidemia to examine the contribution of this risk factor to Notchl-mediated aortic valve calcification. Specific Aim 2: To elucidate the calcific pathways mediated by Notchl in mesenchymal and endocardial cells. Notchl expression will be disrupted or enhanced in cultured mesenchymal and endocardial cells under various conditions. Mesenchymal cells will be examined for activation or repression of osteoblast-specific gene expression and in some cases deposition of calcium. The interactions between Notchl signaling and three molecular pathways previously implicated in cardiovascular calcification, namely Runx2, Bmp2, and Wnt, will be examined. (End of Abstract)
描述(由申请人提供): 主动脉瓣钙化/狭窄是成人心脏病的第三主要原因,也是发达国家获得的瓣膜疾病的最常见形式。与钙化主动脉狭窄最紧密联系的危险因素是存在双质主动脉瓣,年龄增加,男性性别,吸烟,高血压和脂蛋白升高。对人钙化的主动脉瓣组织的检查表明,涉及几种病理途径。但是,尚未阐明参与瓣膜钙化的分子机制。最近,Srivastava实验室报告了两个人类家庭,其中Notch1中的突变与主动脉瓣和双质主动脉瓣的早期钙化有关。 Notchl是许多细胞事件中涉及的高度保守信号通路的一部分,包括细胞命运的决策和细胞分化。这项研究表明,HRT2是介导Notchl信号的转录阻遏物,可以调节Runx2的活性,Runx2是成骨细胞命运的中心调节剂,并在体外确定。我们的初步数据表明,与野生型年龄相比,Notchl杂合小鼠会增加主动脉瓣钙化。我假设NOTCHL信号传导在主动脉瓣间充质中抑制促骨途径,而Notchl破坏可能会使瓣膜敏感到促进钙化的已知危险因素。具体目标1:确定是否破坏NOTCHL信号传导是否通过激活小鼠的成骨途径而导致主动脉瓣的钙化。 NOTCHL信号将在产前或产后有条件地在主动脉瓣组织瓣膜中受到干扰。将检查主动脉瓣的功能狭窄,钙化和与骨形成有关的基因的表达。此外,缺乏缺陷的小鼠将与高脂血症的小鼠模型交叉,以检查这种危险因素对Notchl介导的主动脉瓣钙化的贡献。具体目标2:阐明在中质和心内膜细胞中Notchl介导的钙化途径。在各种条件下,在培养的间质细胞和心内膜细胞中,NOTCHL表达将被破坏或增强。将检查间充质细胞的激活或抑制成骨细胞特异性基因表达,在某些情况下钙的沉积。将检查NOTCHL信号传导与先前与心血管钙化有关的三个分子途径之间的相互作用,即RUNX2,BMP2和WNT。 (抽象的结尾)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VISHAL NIGAM其他文献

VISHAL NIGAM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VISHAL NIGAM', 18)}}的其他基金

Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling
与心肺绕道相关的超生理剪切应力足以激活 RIKP3 信号传导
  • 批准号:
    10606640
  • 财政年份:
    2022
  • 资助金额:
    $ 13.02万
  • 项目类别:
Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling
与心肺绕道相关的超生理剪切应力足以激活 RIKP3 信号传导
  • 批准号:
    10446535
  • 财政年份:
    2022
  • 资助金额:
    $ 13.02万
  • 项目类别:
A Multiscale Modeling Approach to Hypoplastic Left Heart Syndrome
左心发育不全综合征的多尺度建模方法
  • 批准号:
    9053027
  • 财政年份:
    2016
  • 资助金额:
    $ 13.02万
  • 项目类别:
A Multiscale Modeling Approach to Hypoplastic Left Heart Syndrome
左心发育不良综合征的多尺度建模方法
  • 批准号:
    9260047
  • 财政年份:
    2016
  • 资助金额:
    $ 13.02万
  • 项目类别:
A Multiscale Modeling Approach to Hypoplastic Left Heart Syndrome
左心发育不良综合征的多尺度建模方法
  • 批准号:
    9766412
  • 财政年份:
    2016
  • 资助金额:
    $ 13.02万
  • 项目类别:
Mechanisms of Notch1 in Aortic Valve Calcification
Notch1在主动脉瓣钙化中的作用机制
  • 批准号:
    7812206
  • 财政年份:
    2007
  • 资助金额:
    $ 13.02万
  • 项目类别:
Mechanisms of Notch1 in Aortic Valve Calcification
Notch1在主动脉瓣钙化中的作用机制
  • 批准号:
    7483691
  • 财政年份:
    2007
  • 资助金额:
    $ 13.02万
  • 项目类别:
Mechanisms of Notch1 in Aortic Valve Calcification
Notch1在主动脉瓣钙化中的作用机制
  • 批准号:
    8096600
  • 财政年份:
    2007
  • 资助金额:
    $ 13.02万
  • 项目类别:
Mechanisms of Notch1 in Aortic Valve Calcification
Notch1在主动脉瓣钙化中的作用机制
  • 批准号:
    7616412
  • 财政年份:
    2007
  • 资助金额:
    $ 13.02万
  • 项目类别:

相似国自然基金

无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
  • 批准号:
    62372118
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
  • 批准号:
    82300679
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
  • 批准号:
    82301784
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
  • 批准号:
    82301217
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
  • 批准号:
    82373667
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Small molecule therapeutic for calcific aortic valve disease
钙化性主动脉瓣疾病的小分子治疗
  • 批准号:
    10735711
  • 财政年份:
    2023
  • 资助金额:
    $ 13.02万
  • 项目类别:
Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS)
慢性肾功能不全和无症状进展的主动脉瓣狭窄 (CRISP-AS)
  • 批准号:
    10718275
  • 财政年份:
    2023
  • 资助金额:
    $ 13.02万
  • 项目类别:
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
  • 批准号:
    10419907
  • 财政年份:
    2022
  • 资助金额:
    $ 13.02万
  • 项目类别:
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
克隆造血对肾脏疾病进展的影响
  • 批准号:
    10611485
  • 财政年份:
    2022
  • 资助金额:
    $ 13.02万
  • 项目类别:
Investigation of Heart and Vascular Outcomes in Older Veterans
老年退伍军人心脏和血管结局的调查
  • 批准号:
    10618301
  • 财政年份:
    2021
  • 资助金额:
    $ 13.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了